PSX-B-29 Using ozonized flaxseed oil for treatment of postpartum endometritis

Postpartum endometritis is one of the leading causes of infertility in cattle. The study aims to investigate the possibility of using ozonized flaxseed oil (OFO) for treating postpartum purulent-catarrhal endometritis in cows. Ozone was synthesized by using medical ozone generator and chemically pure oxygen. Linseed oil (400.0 ml) was bubbled with an ozone-oxygen mixture for 4 hours through a ceramic sprayer. An ozone concentration at the outlet was 30 mg/l. The therapeutic efficacy of OFO was studied on cattle of the Kholmogory breed with a productivity of 4800 - 5800 kg of milk per year. Thirty animals with symptoms of postpartum purulent-catarrhal endometritis were divided into two groups (n = 15). All of the subjects were in the second and third lactation periods. Animals from both groups were injected with 2% sinestrol solution on days 1 and 3 of treatment. OFO was used in the experimental group (EG). The cattle of the control group (CG) received a 7.5% solution of benzethonium chloride. Drugs were administered intrauterine at a dose of 50–150 ml (depending on the uterus’s size) using a polystyrene pipette, with an interval of 48–72 hours. Cows were inseminated artificially by the cervical method. The pregnancy was determined on the 30-35th day after insemination by ultrasonography. After 5 months of observation, all animals of the CG were pregnant. The pregnancy rate in the EG was 93,3%. In the groups efficiency of the first insemination was 20% and 47%, respectively. In the EG, one impregnation required 1.8±0.2 inseminations, which is 0.5 less than in the CG (2.3±0.3). The duration from calving to impregnation in cows in the EG was 104.4±6.9, 21.2 days less (P < 0.05) than the control, where the period was 125.6±7.6. Thus, OFO can be effectively used for the treatment of endometritis in cattle.

Ozone in Medicine. The Low-Dose Ozone Concept and Its Basic Biochemical Mechanisms of Action in Chronic Inflammatory Diseases

Low-dose ozone acts as a bioregulator in chronic inflammatory diseases, biochemically characterized by high oxidative stress and a blocked regulation. During systemic applications, “Ozone peroxides” are able to replace H2O2 in its specific function of regulation, restore redox signaling, and improve the antioxidant capacity. Two different mechanisms have to be understood. Firstly, there is the direct mechanism, used in topical treatments, mostly via radical reactions. In systemic treatments, the indirect, ionic mechanism is to be discussed: “ozone peroxide” will be directly reduced by the glutathione system, informing the nuclear factors to start the regulation. The GSH/GSSG balance outlines the ozone dose and concentration limiting factor. Antioxidants are regulated, and in the case of inflammatory diseases up-regulated; cytokines are modulated, here downregulated. Rheumatoid arthritis RA as a model for chronic inflammation: RA, in preclinical and clinical trials, reflects the pharmacology of ozone in a typical manner: SOD (superoxide dismutase), CAT (catalase) and finally GSH (reduced glutathione) increase, followed by a significant reduction of oxidative stress. Inflammatory cytokines are downregulated. Accordingly, the clinical status improves. The pharmacological background investigated in a remarkable number of cell experiments, preclinical and clinical trials is well documented and published in internationally peer reviewed journals. This should encourage clinicians to set up clinical trials with chronic inflammatory diseases integrating medical ozone as a complement.

Use of medical ozone in fail back surgery syndrome: a systematic review.

The safety and efficacy of ozone injections in the spine for lumbar disc herniation has been proved in two systematic reviews with one metaanalysis. Many other papers with lower evidence level were published before encouraging its use for this pathology and other degenerative spinal diseases. Fail back surgery syndrome (FBSS) is a terrible situation with no clear treatment option presently. Some authors have dared to use ozone injections in these patients, based on its antiinflammatory action and its highly save portfolio. Due to the great disability and dramatic situation of FBSS patients, a systematic review is mandatory in order to clarify the potential role of ozone in this pathology.

The diamod tip.

This issue 5 is devoted to spine diseases that can be treated or improved by using medical ozone. Dr. Alberto Alexandre compiled during 2015 and 2016 a number of papers from experienced authors in order to prepare a monographic issue but found a lot of difficulty in publishing it. I offered him our Journal to publish these scientific works and he agreed. COVID-19 pandemic has produce a huge increase in publishing time for all journals but we finally have been able to produce this issue. Due to the delay in its publication, some papers have been published by their authors in other journals. We are hardly working in issue 6 that will be opened for different topics and we are preparing issue 7 that we expect to be a monographic on dental applications. All papers are welcomed!

Medical Ozone: The Pharmacological Mechanisms Accounting for its Effectiveness against COVID-19/SARS-COV-2

Introduction: Medical ozone has been used with safety and efficacy in different diseases of oxidative etiology, for the most part involving autoimmune diseases. Methods: An analysis of the pharmacological mechanism of action of ozone was carried out to explain its clinical effectiveness and its positive response in clinical patients to COVID-19. This was done in the context of the different therapeutic targets that have been demonstrated for ozone in other diseases (autoimmune and hypoxia status). Results: Based on the intestine/lung functional axis, the necessity of rectal insufflation as route of application with the aim of attaining improved results using medical ozone against COVID 19 is demonstrated. It was possible to identify at least nine adverse events/molecules which were targets of regulation through medical ozone in other diseases, including innate immune response, nuclear transcription factor NF-kB, “cytokine storm”, inflammation, severe acute respiratory syndrome and coagulopathy. Some of them lead to multi organ failure. Finally, a brief analysis is undertaken to show the regulatory effects of ozone versus the comorbidities contributing to virus lethality, including hyperglycemia and its vascular complications. Conclusions: Medical ozone is effective against COVID-19/SARS-CoV-2: due to the multiple targets it is able to regulate and thereby achieve a positive patient response.

Modern aspects of professional cancer treatment: prospects for the use of medical ozone in the correction of free radical homeostasis

Introduction. The well-known features of oncogenesis make it possible to assume the prospects of medical ozone as part of a comprehensive health-saving therapy for professional oncopathologies. Due to the risk of stimulating the proliferation of tumor cells, research on the search for optimal modes of ozone exposure is relevant. The aim of the study was to evaluate the possibility of using ozonated saline solution (OSS) as part of complex antitumor therapy in an experiment. Materials and methods. The effect of OSS with different concentrations of ozone in the ozone-oxygen mixture on the content of hemoglobin, active products of thiobarbituric acid (TBA) of lipid peroxidation (LP), the degree of oxidative modification of proteins, and the activity of superoxide dismutase and catalase in blood, liver, spleen, and tumor tissues was studied in Mature rats with normal and transplanted cholangiocellular carcinoma. Results. The course effect of the OSS did not have statistically significant changes in the studied biochemical parameters under the conditions of the physiological norm in the experiment. Exposure to OSS during oncogenesis led to a decrease in the content of TBA-active LP products in the liver by more than 30%. Conclusions. Course exposure to OSS with an ozone concentration in an ozone-oxygen mixture of 400 micrograms/l may be promising for the correction of free radical homeostasis as part of complex antitumor therapy, including in oncogenesis due to occupational factors.